Repligen
RGEN
#2598
Rank
โ‚น630.25 B
Marketcap
โ‚น11,175
Share price
0.27%
Change (1 day)
4.60%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: โ‚น630.25 Billion

As of April 2026 Repligen has a market cap of โ‚น630.25 Billion. This makes Repligen the world's 2598th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น630.25 B-24.96%
2025โ‚น839.89 B20.07%
2024โ‚น699.51 B-16.3%
2023โ‚น835.70 B7.43%
2022โ‚น777.91 B-28.62%
2021โ‚น1.089 T42.12%
2020โ‚น766.84 B123.23%
2019โ‚น343.52 B112.11%
2018โ‚น161.95 B60.48%
2017โ‚น100.91 B42.43%
2016โ‚น70.85 B14.39%
2015โ‚น61.94 B50.62%
2014โ‚น41.12 B52.87%
2013โ‚น26.90 B150.81%
2012โ‚น10.72 B90.25%
2011โ‚น5.63 B-12.86%
2010โ‚น6.47 B10.29%
2009โ‚น5.86 B3.54%
2008โ‚น5.66 B-29.03%
2007โ‚น7.98 B111.1%
2006โ‚น3.78 B-30.23%
2005โ‚น5.42 B44.5%
2004โ‚น3.75 B-37.03%
2003โ‚น5.95 B49.46%
2002โ‚น3.98 B27.27%
2001โ‚น3.13 B-25.22%
2000โ‚น4.18 B38.09%
1999โ‚น3.03 B209.27%
1998โ‚น0.98 B77.46%
1997โ‚น0.55 B-18.65%
1996โ‚น0.67 B

End of Day market cap according to different sources

On Apr 9th, 2026 the market cap of Repligen was reported to be:

โ‚น628.57 Billion
by Nasdaq info icon info icon
โ‚น628.57 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น14.248 T 2,160.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น17.154 T 2,621.84%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น30.263 T 4,701.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.136 T 1,666.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น9.68 B-98.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น123.10 B-80.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น1.203 T 90.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น808.51 B 28.28%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น975.80 B 54.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น806.42 B 27.95%๐Ÿ‡บ๐Ÿ‡ธ USA